Affordable Access

Publisher Website

Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.

Authors
Type
Published Article
Journal
Molecular Cancer Research
1557-3125
Publisher
American Association for Cancer Research
Publication Date
Volume
7
Issue
6
Pages
897–906
Identifiers
DOI: 10.1158/1541-7786.MCR-08-0519
PMID: 19470598
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments